179 related articles for article (PubMed ID: 26806782)
1. Clinical neuroscience of amphetamine-type stimulants: From basic science to treatment development.
Courtney KE; Ray LA
Prog Brain Res; 2016; 223():295-310. PubMed ID: 26806782
[TBL] [Abstract][Full Text] [Related]
2. The neurotoxicity of amphetamines during the adolescent period.
Teixeira-Gomes A; Costa VM; Feio-Azevedo R; Bastos Mde L; Carvalho F; Capela JP
Int J Dev Neurosci; 2015 Apr; 41():44-62. PubMed ID: 25482046
[TBL] [Abstract][Full Text] [Related]
3. Could sigma receptor ligands be a treatment for methamphetamine addiction?
Rodvelt KR; Miller DK
Curr Drug Abuse Rev; 2010 Sep; 3(3):156-62. PubMed ID: 21054260
[TBL] [Abstract][Full Text] [Related]
4. Advances and challenges in pharmacotherapeutics for amphetamine-type stimulants addiction.
Cao DN; Shi JJ; Hao W; Wu N; Li J
Eur J Pharmacol; 2016 Jun; 780():129-35. PubMed ID: 27018393
[TBL] [Abstract][Full Text] [Related]
5. Does chronic use of amphetamine-type stimulants impair interference control? - A meta-analysis.
Opitz A; Petasch MS; Klappauf R; Kirschgens J; Hinz J; Dittmann L; Dathe AS; Quednow BB; Beste C; Stock AK
Neurosci Biobehav Rev; 2023 Mar; 146():105020. PubMed ID: 36581170
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic landscape of amphetamine and methamphetamine addiction in rodents.
Godino A; Jayanthi S; Cadet JL
Epigenetics; 2015; 10(7):574-80. PubMed ID: 26023847
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in abusers of amphetamine-type stimulants and ketamine in southwestern China.
Zhang Y; Lu C; Zhang J; Hu L; Song H; Li J; Kang L
Addict Behav; 2013 Jan; 38(1):1424-30. PubMed ID: 23006246
[TBL] [Abstract][Full Text] [Related]
8. On the necessity of translational cognitive-neurotoxicological research in methamphetamine abuse and addiction.
Stock AK; Beste C
Arch Toxicol; 2017 Jul; 91(7):2707-2709. PubMed ID: 28444486
[No Abstract] [Full Text] [Related]
9. Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature.
Courtney KE; Ray LA
Drug Alcohol Depend; 2014 Oct; 143():11-21. PubMed ID: 25176528
[TBL] [Abstract][Full Text] [Related]
10. Early Initiation of Amphetamine-Type Stimulants (ATS) Use Associated with Lowered Cognitive Performance among Individuals with Co-Occurring Opioid and ATS Use Disorders in Malaysia.
Chooi WT; Mohd Zaharim N; Desrosiers A; Ahmad I; Yasin MAM; Syed Jaapar SZ; Schottenfeld RS; Vicknasingam BK; Chawarski MC
J Psychoactive Drugs; 2017; 49(4):326-332. PubMed ID: 28661714
[TBL] [Abstract][Full Text] [Related]
11. Treatments for methamphetamine abuse: a literature review for the clinician.
Brackins T; Brahm NC; Kissack JC
J Pharm Pract; 2011 Dec; 24(6):541-50. PubMed ID: 22095579
[TBL] [Abstract][Full Text] [Related]
12. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs.
Cunha-Oliveira T; Rego AC; Oliveira CR
Brain Res Rev; 2008 Jun; 58(1):192-208. PubMed ID: 18440072
[TBL] [Abstract][Full Text] [Related]
13. Stimulant substitution in methamphetamine dependence.
Dobry Y; Sher L
Aust N Z J Psychiatry; 2012 Dec; 46(12):1201-2. PubMed ID: 22689332
[No Abstract] [Full Text] [Related]
14. Methods in drug abuse models: comparison of different models of methamphetamine paradigms.
Kobeissy FH; Mitzelfelt JD; Fishman I; Morgan D; Gaskins R; Zhang Z; Gold MS; Wang KK
Methods Mol Biol; 2012; 829():269-78. PubMed ID: 22231820
[TBL] [Abstract][Full Text] [Related]
15. The methamphetamine experience: a NIDA partnership.
Hanson GR; Rau KS; Fleckenstein AE
Neuropharmacology; 2004; 47 Suppl 1():92-100. PubMed ID: 15464128
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoid mechanism in amphetamine-type stimulant use disorders: A short review.
Su H; Zhao M
J Clin Neurosci; 2017 Dec; 46():9-12. PubMed ID: 28912087
[TBL] [Abstract][Full Text] [Related]
17. The neurobiological mechanisms of physical exercise in methamphetamine addiction.
Morais APD; Pita IR; Fontes-Ribeiro CA; Pereira FC
CNS Neurosci Ther; 2018 Feb; 24(2):85-97. PubMed ID: 29266758
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological treatments for methamphetamine addiction: current status and future directions.
Ballester J; Valentine G; Sofuoglu M
Expert Rev Clin Pharmacol; 2017 Mar; 10(3):305-314. PubMed ID: 27927042
[TBL] [Abstract][Full Text] [Related]
19. Molecular, Behavioral, and Physiological Consequences of Methamphetamine Neurotoxicity: Implications for Treatment.
Moszczynska A; Callan SP
J Pharmacol Exp Ther; 2017 Sep; 362(3):474-488. PubMed ID: 28630283
[TBL] [Abstract][Full Text] [Related]
20. Recent topics on pharmacotherapy for amphetamine-type stimulants abuse and dependence.
Chen H; Wu J; Zhang J; Hashimoto K
Curr Drug Abuse Rev; 2010 Dec; 3(4):222-38. PubMed ID: 21208168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
